Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of cytotoxic therapy on clonal hematopoiesis and myeloid neoplasms in breast cancer patients.

Medicine - 15 Nov 2024

Kim Heyjin, Jin Hyeon-Ok, Kim Ji-Young, Hong Young Jun, Lee Jin Kyung

Abstract excerpt

Clonal hematopoiesis (CH), which is characterized by variants of hematopoietic stem cells, increases the risk of subsequent myeloid neoplasms (MNs). This study aimed to investigate the prevalence and characteristics of CH variants in breast cancer (BC) patients treated with cytotoxic therapy (CT), focusing on those who developed MNs after cytotoxic therapy (MN-pCT). We retrospectively analyzed 107 BC patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Antineoplastic Agents
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Clonal Hematopoiesis

Share to Gene Frequency

Share to Mutation

Share to Neoplasms, Second Primary

Source

Open in PubMed Open full text

Identifiers

PMID: 39560556
DOI: 10.1097/MD.0000000000040540
PMCID: PMC11575989

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of cytotoxic therapy on clonal hematopoiesis and myeloid neoplasms in breast cancer patients.PMID 39560556Read ↗

Clonal hematopoiesis in older patients with breast cancer receiving chemotherapy.Semantic proximity Read ↗

Clonal Hematopoiesis in Young Women Treated for Breast Cancer.Semantic proximity Read ↗

Germline DNA Repair Gene Mutations and Clonal Hematopoiesis (CH) in 24,849 Patients with BRCA-Associated CancersSemantic proximity Read ↗

Impact of cancer therapy on clonal hematopoiesis mutations and subsequent clinical outcomes.Semantic proximity Read ↗

Clonal Hematopoiesis Dynamics and Evolutionary Fitness During Cancer Treatment Impact Clinical OutcomesSemantic proximity Read ↗

Evolution of clonal hematopoiesis during cancer treatment and its impact on outcomes.Semantic proximity Read ↗

Distinct landscape and clinical implications of therapy-related clonal hematopoiesis.Semantic proximity Read ↗

Tumor-Infiltrating Clonal Hematopoiesis and Pan-Cancer Prognosis in Patients With Solid Tumors.Semantic proximity Read ↗

Ontogeny and Natural History of Therapy-Related Clonal Hematopoiesis From a Multidisciplinary CHIP Clinic.Semantic proximity Read ↗

Cancer therapy shapes the fitness landscape of clonal hematopoiesis.Semantic proximity Read ↗

Clonal Hematopoiesis in Women With Breast CancerSemantic proximity Read ↗

Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.